Education
About Us
Working with TipRanks
Follow Us
Agilent Technologies (A)
NYSE:A
A Stock Chart & Stats
$132.14
-$0.52(-0.38%)
At close: 4:00 PM EST
$132.14
-$0.52(-0.38%)
Day’s Range― - ―
52-Week Range$96.43 - $160.27
Previous CloseN/A
Volume231.77K
Average Volume (3M)1.62M
Market Cap
$38.29B
Enterprise Value$39.04B
Total Cash (Recent Filing)$1.79B
Total Debt (Recent Filing)$3.35B
Price to Earnings (P/E)29.6
Beta0.96
Next Earnings
Feb 25, 2026EPS Estimate
1.37Next Dividend Ex-DateN/A
Dividend Yield0.72%
Share Statistics
EPS (TTM)1.59
Shares Outstanding282,839,630
10 Day Avg. Volume1,842,583
30 Day Avg. Volume1,622,263
Financial Highlights & Ratios
PEG Ratio9.41
Price to Book (P/B)6.14
Price to Sales (P/S)5.96
P/FCF Ratio35.95
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue2.22
Enterprise Value/Gross Profit4.24
Enterprise Value/Ebitda8.22
Forecast
1Y Price Target
$171.67Price Target Upside29.92% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Instrument Replacement CycleAn ongoing replacement cycle in liquid chromatography and mass spectrometry is driving upgrade purchases for instruments and consumables, supporting steady revenue from recurring customer demand.
Margin Improvement ProgramMargin recovery tied to the Ignite cost program and organizational streamlining is expected to enhance profitability and operational efficiency.
Pharma And CDMO DemandStronger demand from contract drug manufacturers and accelerated adoption by pharma of oligonucleotide, peptide and mRNA workflows is expanding service and consumable sales.
Bears Say
Academic And Government SpendingPersistent weakness among academic and government customers could limit the company’s revenue recovery in certain end markets and reduce upside to instrument sales.
China Regulatory And Competitive RiskDynamic tariff policies and intensified local competition in China may pressure regional margins and slow growth in a key geographic market.
Tax Rate Impact On EarningsAn unexpected increase in the effective tax rate has lowered adjusted EPS guidance, reducing near term earnings momentum despite solid top line trends.
Agilent News
A FAQ
What was Agilent Technologies’s price range in the past 12 months?
Agilent Technologies lowest stock price was $96.43 and its highest was $160.27 in the past 12 months.
What is Agilent Technologies’s market cap?
Agilent Technologies’s market cap is $38.29B.
When is Agilent Technologies’s upcoming earnings report date?
Agilent Technologies’s upcoming earnings report date is Feb 25, 2026 which is in 21 days.
How were Agilent Technologies’s earnings last quarter?
Agilent Technologies released its earnings results on Oct 31, 2025. The company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.584 by $0.006.
Is Agilent Technologies overvalued?
According to Wall Street analysts Agilent Technologies’s price is currently Undervalued.
Does Agilent Technologies pay dividends?
Agilent Technologies pays a Quarterly dividend of $0.255 which represents an annual dividend yield of 0.72%. See more information on Agilent Technologies dividends here
What is Agilent Technologies’s EPS estimate?
Agilent Technologies’s EPS estimate is 1.37.
How many shares outstanding does Agilent Technologies have?
Agilent Technologies has 282,839,630 shares outstanding.
What happened to Agilent Technologies’s price movement after its last earnings report?
Agilent Technologies reported an EPS of $1.59 in its last earnings report, beating expectations of $1.584. Following the earnings report the stock price went down -1.141%.
Which hedge fund is a major shareholder of Agilent Technologies?
Currently, no hedge funds are holding shares in A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Agilent Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$171.67 (29.92% Upside)
$171.67 (29.92% Upside)
Blogger Sentiment
Bullish
A Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 768.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $483.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 6.9%
Last 30 Days ▼ 0.9%
Last 30 Days ▼ 0.9%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-10.37%
12-Months-Change
Fundamentals
Return on Equity
20.62%
Trailing 12-Months
Asset Growth
7.07%
Trailing 12-Months
Company Description
Agilent Technologies
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
A Revenue Breakdown
39.23% Life Sciences and Diagnostics Markets
41.85% Agilent CrossLab
18.91% Applied Markets
A Stock 12 Month Forecast
Average Price Target
$171.67
▲(29.92% Upside)
Technical Analysis
Ownership Overview
0.25% Insiders
27.40% Mutual Funds
0.25% Other Institutional Investors
47.25% Public Companies and Individual Investors